These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8342427)

  • 1. [Response of superficial bladder carcinoma to prophylacit treatment with mitomycin-C versus interferon. Preliminary study].
    Regueiro López JC; Alvarez-Cienfuegos FR; Leva Vallejo M; Prieto Castro R; Merchan García JA; Saceda López JL; Requena Tapia MJ; López-Pardo RL
    Actas Urol Esp; 1993 May; 17(5):299-304. PubMed ID: 8342427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.
    Colombo R; Da Pozzo LF; Salonia A; Rigatti P; Leib Z; Baniel J; Caldarera E; Pavone-Macaluso M
    J Clin Oncol; 2003 Dec; 21(23):4270-6. PubMed ID: 14581436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
    Schwaibold H; Klingenberger HJ; Huland H
    Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experience with mitomycin C in the prophylaxis of superficial bladder tumors; retrospective study].
    Moyano Calvo JL; Herrero Torres L; Melón Rey FJ; Rabadán Ruiz M; Pereira Sanz I
    Arch Esp Urol; 1994 Oct; 47(8):750-4. PubMed ID: 7818293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
    Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H
    BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovesical instillation of mitomycin-C in preventing recurrence of superficial bladder carcinoma.
    Wu JJ; Yin ZL; Zhu JN
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1160-3. PubMed ID: 1514829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG].
    Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M
    Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A prospective and randomized study of the complete response, index of recurrences and progression in superficial bladder carcinoma treated with mitomycin C alone versus mitomycin C and BCG alternatively].
    Gelabert-Mas A; Arango Toro O; Bielsa Gali O; Lladó Carbonell C
    Arch Esp Urol; 1993 Jun; 46(5):379-82. PubMed ID: 8342972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
    Imamoğlu MA; Bakirtaş H; Yiğitbaşi O; Ersoy H; Sertçelik AN
    Arch Esp Urol; 2001 Dec; 54(10):1147-53. PubMed ID: 11852530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis of superficial bladder cancer with 1 mg of intravesical BCG: comparison with other doses].
    Corti Ortíz D; Rivera Garay P; Avilés Jasse J; Hidalgo Carmona F; MacMillan Soto G; Coz Cañas LF; Vargas Delaunoy R; Susaeta Saénz de San Pedro R
    Actas Urol Esp; 1993 Apr; 17(4):239-42. PubMed ID: 8342413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
    Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
    Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local mitomycin-C therapy in relapse-prevention of superficial bladder neoplasms treated by means of laser.
    Szemes Z; Kovács R
    Acta Chir Hung; 1994; 34(1-2):5-10. PubMed ID: 7604628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
    Liu B; Zhang Y; Wang Z; Ding Q; Chen B; Wang J; Jiang H
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrino-necrotic ulcers in endovesical chemoprophylaxis in superficial bladder carcinoma: our case histories].
    Guinda Sevillano C; Arnáiz Esteban F; Fernández Rosáenz J; Pérez Arbej JA; Martínez Pérez E; Nogueras Gimeno MA; Espuela Orgaz R
    Actas Urol Esp; 1994 May; 18(5):555-8. PubMed ID: 8079679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.